Antares Pharma, Inc. (ATRS)

Net Income Growth

-161.19%

Quarterly · Period ending:

ATRS logo

ATRS Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-161.19%
ATRS Quarterly Net Income YoY % (-20.00% → -161.19%)
High-resolution chart · PNG

ATRS net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Net Income Growth — Quarterly
Period endingNet Income Growth
-161.1917%
-36.3971%
7.9464%
208.3218%
260.9932%
994.4835%
379.0029%
197.7089%
57.4652%
-23.4594%
153.874%
50.7522%
10.5603%
265.1314%
64.4935%
-59.1581%
-30.7666%
17.4575%
10.9208%
53.1475%
38.142%
32.087%
-6.6737%
-302.315%
-12.7943%
34.215%
20.1546%
83.4393%
22.82%
-78.7531%
-12.9951%
-78.2729%
-158.0237%
-12.4382%
-79.9527%
-81.8%
-4,481.6168%
-3,155.8387%
-172.0196%
-80.624%
94.6116%
88.1464%
20.3593%
-0.1187%
14.1901%
46.04%
43.625%
31.1215%
41.2088%
12.2688%
9.251%
30.8872%
21.7569%
15.3763%
-22.1433%
-41.9554%
-714.2115%
-129.2949%
-35.6318%
6.5007%
81.3591%
26.3966%
2.6187%
-5.5425%
-1.3922%
24.5097%
10.93%
-37.6877%
-19.9768%
8.6731%
90.494%
53.9295%
37.2176%
24.5587%
-505.993%
-91.4336%
-40.5662%
-22.706%
-78.6068%
-14.187%
-32.8098%
-41.2211%
-91.6755%
-83.0589%
-91.8553%
-63.497%
-2.2984%
8.296%
-180.824%
49.2719%
15.3846%
9.0909%
62.5%
-282.4933%
-44.4444%
-37.5%
-33.3333%
-24.7321%
-50%
-33.3333%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.